Is HAE a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

141 people get HAE articles and Market Currents by email alert.

Get email alerts on HAE »

HEADLINES:

Haemonetics Corporation - Analyst/Investor Day
Thu, May 16
Haemonetics Management Discusses Q4 2013 Results - Earnings Call Transcript
Wed, May 1
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance

PR Newswire (May 1, 2013)
Haemonetics Completes Hemerus Medical, LLC Acquisition

PR Newswire (May 1, 2013)
Haemonetics Sets Date for Investor/Analyst Meeting

PR Newswire (Apr 24, 2013)
Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013

PR Newswire (Apr 1, 2013)
Haemonetics' CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Tue, Feb 26
Haemonetics to Present at The Raymond James Institutional Investors Conference

PR Newswire (Feb 25, 2013)
Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety

PR Newswire (Feb 14, 2013)
Haemonetics to Present at Citi 2013 Global Healthcare Conference

PR Newswire (Feb 13, 2013)
Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference

PR Newswire (Feb 6, 2013)
Haemonetics Management Discusses Q3 2013 Results - Earnings Call Transcript
Wed, Jan 30
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70

PR Newswire (Jan 30, 2013)
Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013

PR Newswire (Jan 9, 2013)
Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference

PR Newswire (Jan 4, 2013)
Haemonetics to Present at the 31st Annual J.P. Morgan Health Care Conference

PR Newswire (Dec 21, 2012)
5 Biotechs With Short Squeeze Potential Hitting New 52 Week Highs
Heisenberg Principle • Tue, Dec 11, 2012 • 1 Comment
Haemonetics Effects 2-For-1 Split of Its Common Stock

PR Newswire (Dec 3, 2012)
Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split

PR Newswire (Oct 29, 2012)
Haemonetics Announces Roll Out of its BloodTrack Solution to 51 Hospitals Across Ireland

PR Newswire (Oct 19, 2012)

To learn more about Seeking Alpha Pro, click here.

No Bleeding at Haemonetics
David Greene • Mon, Aug 23, 2010
Haemonetics: Q3 Results Mixed
Zacks Investment Research • Mon, Mar 15, 2010
Sticking with Haemonetics
Robert Freedland • Tue, May 5, 2009
Haemonetics: About to Start Bleeding Profits?
Joe Kunkle • Fri, Oct 17, 2008
Haemonetics Corporation: Market Leader in Blood Recycling
The Wall Street Transcript • Mon, Apr 30, 2007
Telecom IPO: Globalstar Files an S-1 (GLOB)
SA Editor Abbi Adest • Tue, Jul 18, 2006 • 1 Comment

5 Biotechs With Short Squeeze Potential Hitting New 52 Week Highs
Heisenberg Principle • Tue, Dec 11, 2012 • 1 Comment
6 Low-Debt And Liquid Small Cap Healthcare Stocks
ZetaKap • Fri, Aug 24, 2012
5 Highly Liquid Medical Device Stocks With Encouraging Receivable Trends
Kapitall • Tue, Jul 24, 2012
Billionaire Jim Simons And Insiders Are Bullish About These Stocks
Insider Monkey • Thu, Dec 8, 2011
10 Oversold, No Debt Stocks Operating With Impressive Profitability
Follow My Alpha • Mon, Nov 21, 2011
Options Traders Are Bullish On These 20 Healthcare Stocks
Kapitall • Wed, Nov 2, 2011
10 Oversold, Profitable Firms Trading Near 52-Week Lows
Follow My Alpha • Wed, Oct 26, 2011
Fisher Investments' Healthcare Picks: Large Caps Trumping Small Caps
Zvi Bar • Thu, Jul 14, 2011 • 6 Comments
Searching for Stocks in Economy's Slow Move Forward
Erik Dellith • Tue, Jun 28, 2011 • 2 Comments
7 New Healthcare Buys for Kenneth Fisher
Efsinvestment • Mon, Jun 6, 2011 • 4 Comments
The Best and Worst Medical Device Stocks
Insider Monkey • Wed, Apr 27, 2011 • 7 Comments
10 Buys With Historically Low Price to Book Ratios
Investment Underground • Wed, Apr 6, 2011 • 8 Comments
Healthcare Sector: Stronger Than It Looks
Alan Brochstein • Tue, Feb 8, 2011 • 2 Comments
Competitive Technologies: Short Squeeze Coming or Another Leg Down?
David Greene • Wed, Aug 25, 2010 • 29 Comments
5 Heavily Shorted Stocks With Significant Insider Buying
Kapitall • Mon, Aug 23, 2010 • 7 Comments
Haemonetics Receives Approval
Zacks Investment Research • Wed, Feb 24, 2010
Are Insiders Buying More or Selling More Now?
Philip Davis • Sun, Feb 21, 2010 • 15 Comments
Forbes' 200 Best Small Companies Through the Magic Formula Screen
MagicDiligence • Wed, Dec 2, 2009 • 5 Comments
Activist Investments in September 2009
Greenbackd • Thu, Oct 15, 2009
Small Laggards: Suggestions for Chasing the Market
Alan Brochstein • Thu, Sep 24, 2009 • 3 Comments

Haemonetics Corporation - Analyst/Investor Day
Thu, May 16
Haemonetics Management Discusses Q4 2013 Results - Earnings Call Transcript
Wed, May 1
Haemonetics' CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Tue, Feb 26
Haemonetics Management Discusses Q3 2013 Results - Earnings Call Transcript
Wed, Jan 30
Haemonetics Corporation F3Q09 Earnings Call Transcript
Mon, Feb 2, 2009
Haemonetics Corp. F4Q08 (Qtr End 03/29/08) Earnings Call Transcript
Fri, May 16, 2008
Haemonetics Corp. F4Q08 (Qtr End 03/29/08) Earnings Call Transcript
Tue, May 13, 2008

Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance

PR Newswire (May 1, 2013)
Haemonetics Completes Hemerus Medical, LLC Acquisition

PR Newswire (May 1, 2013)
Haemonetics Sets Date for Investor/Analyst Meeting

PR Newswire (Apr 24, 2013)
Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013

PR Newswire (Apr 1, 2013)
Haemonetics to Present at The Raymond James Institutional Investors Conference

PR Newswire (Feb 25, 2013)
Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety

PR Newswire (Feb 14, 2013)
Haemonetics to Present at Citi 2013 Global Healthcare Conference

PR Newswire (Feb 13, 2013)
Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference

PR Newswire (Feb 6, 2013)
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70

PR Newswire (Jan 30, 2013)
Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013

PR Newswire (Jan 9, 2013)
Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference

PR Newswire (Jan 4, 2013)
Haemonetics to Present at the 31st Annual J.P. Morgan Health Care Conference

PR Newswire (Dec 21, 2012)
The Technical Indicator: Bulls, bears make case while surfing fiscal cliff

at MarketWatch.com (Dec 4, 2012)
Haemonetics Effects 2-For-1 Split of Its Common Stock

PR Newswire (Dec 3, 2012)
Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split

PR Newswire (Oct 29, 2012)
Haemonetics Announces Roll Out of its BloodTrack Solution to 51 Hospitals Across Ireland

PR Newswire (Oct 19, 2012)
Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference

PR Newswire (Oct 18, 2012)
Haemonetics Showcases Entire Product Portfolio at AABB Meeting in Boston

PR Newswire (Oct 4, 2012)
Haemonetics Sets Date for Second Quarter Fiscal Year 2013 Earnings Release: October 29, 2012

PR Newswire (Sep 25, 2012)
Haemonetics Provides Update on Hemerus Medical, LLC Acquisition

PR Newswire (Sep 17, 2012)

HAE vs. ETF Alternatives

Company Description

Our Company was founded in 1971 and became publicly owned for the first time in 1979. In 1983, American Hospital Supply Corporation (“AHS”) acquired us. When Baxter Travenol Laboratories, Inc. (“Baxter”) acquired AHS in 1985, Baxter divested the Haemonetics business to address antitrust concerns... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 1, 7:24 AM Haemonetics (HAE): FQ4 EPS of $0.48 beats by $0.02. Revenue of $249.9M (+34% Y/Y) beats by $0.57M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, January 30, 10:13 AM Haemonetics (HAE -8.4%) slides after reporting a mixed FQ3, beating on the bottom line but coming up short on top line revenue. Total sales increased by 19% Y/Y, with organic revenue growth of 11% in Asia and 2% in Europe. which were partially offset by declines of 1% in North America and 2% in Japan. The company reaffirms its outlook for FY13, expecting an EPS of $1.65 - $1.70 on revenues of $888M - $898M, below the Street view for an EPS of $1.70 on revenues of $900M. Comment! [Healthcare, Earnings, On the Move]
Wednesday, January 30, 6:07 AM Haemonetics (HAE): FQ3 EPS of $0.5 beats by $0.02. Revenue of $247.4M (+19% Y/Y) misses by $4.53M. (PR) Comment! [Earnings, Healthcare, Breaking News]
Tuesday, October 30, 2012, 2:49 PM Haemonetics (HAE) Q2 results came in mixed late yesterday, beating on a per share basis, but coming up slight shy on the revenue side. Total revenue was up nearly 22% Y/Y however, on continued strength in across its entire product portfolio. Barrington thinks the quarter was strong believes that its integration of PALL is proceeding better than expected. The firm raised its target on the stock to $88 from $79 yesterday and reiterates an Outperform on the stock. Comment! [Earnings]
Monday, October 29, 2012, 6:26 AM Haemonetics (HAE): Q3 EPS of $0.90 beats by $0.13. Revenue of $218.2M (+21.6% Y/Y) misses by $5M. The company announces two-for-one split. (PR) Comment! [Earnings, Healthcare]
Tuesday, September 18, 2012, 2:02 PM Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off until next March after the start of its 2014 fiscal year. The company notes that U.S. regulators are asking for more information about its SOLX whole-blood collection system as part of a resubmitted marketing application. Comment! [Healthcare, M&A]
Monday, April 30, 2012, 6:11 AM Haemonetics (HAE): Q1 EPS of $0.80 misses by $0.03. Revenue of $186.7M (+9.8% Y/Y) beats by $3M. (PR) Comment! [Earnings, Healthcare]
Monday, April 30, 2012, 3:24 AM Pall Corp (PLL) said yesterday it will sell some of its blood collection, filtration and processing product lines to Haemonetics Corp (HAE) for ~$550M. Separately, Haemonetics announced it will acquire the business assets of Hemerus Medical, a company that develops innovative blood technologies. Comment! [M&A, Healthcare]
Monday, January 30, 2012, 8:08 AM Haemonetics (HAE): FQ3 EPS of $0.86 beats by $0.80. Revenue of $191.2M (+8.1% Y/Y) beats by $5M. (PR) Comment! [Earnings, Healthcare]
Monday, October 31, 2011, 12:41 PM Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates, despite beating on revenue. Profits rose 8% Y/Y, but net income declined 35% due to quality issues with its HS Core Bowl and the recall of its OrthoPAT device. Comment! [Healthcare, On the Move]
Monday, August 1, 2011, 10:47 AM Medical device maker Haemonetics (HAE -7%) takes a hit as its FQ1 earnings miss the mark due to a product recall. The company also reduces FY guidance, citing "significant headwinds" it faces over regulatory and economic concerns. Comment! [Healthcare, Earnings, On the Move]
Monday, November 1, 2010, 8:08 AM Haemonetics (HAE): FQ2 EPS of $0.80 beats by $0.04. Revenue of $167M (+6.2%) vs. $174M. (PR) Comment!
Monday, November 1, 2010, 12:05 AM Notable earnings before Monday's open: AAWW, ACOR, ACV, AGN, ALR, BHI, CNA, CNL, CTB, CTSH, ENDP, GLW, HAE, HUM, ICE, IPGP, JKS, L, MCY, PTV, RE, SNH, SPG, WRI Comment!

Ocean Man
Sold $HAE for a gain of 4.5% in 2 weeks. $37.98 ---> $39.71. http://seekingalpha.com/s/egxax
May 15, 1:58 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ocean Man
Bought $HAE at $37.98. Great report yesterday, gapped up from $38.50 to $40.00, then fell with the market to $37.75. Upgraded today.
May 2, 9:37 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Low-Debt And Liquid Small Cap Healthcare Stocks http://bit.ly/QafuOU $AMAG $ARTC $CYBX $DXCM $MASI $HAE @ZetaKap
8/24/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
Another channeler: HAE dropping from $59-$60 upper channel towards $52.50 lower bound. Stock's been stuck in this range since early 2008.
10/7/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Smart-Ticker.com
Top Bears $BAX,$CTL,$TLCR,$ALGN,$NOK,$HAE,$ABB,$EBAY,$ADTN,$RS...more http://s-t.cc
4/22/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

HAE Haemonetics Corp

HAE

Haemonetics Corp